Type VII collagen is an important protein that helps hold the skin together. Patients with a severe skin condition known as recessive dystrophic epidermolysis bullosa (RDEB) have genetic mutations that lead to reductions ...
Oct 23, 2015
0
48
A lot of time, money, and effort are devoted to developing new drugs. Yet only one of every 10 drug candidates entering human clinical trials successfully goes on to receive approval from the Food and Drug Administration ...
Oct 1, 2015
0
5
Brain lesions in children can be especially challenging to diagnose, according to a report in the journal Frontiers in Neurology by a multidisciplinary team of Loyola University Medical Center physicians.
Jun 9, 2015
0
10
A cancer drug that helps keep tumors from growing blood vessels may help patients with a rare genetic condition in which malformed vessels increase their risk for bleeding and anemia.
Mar 16, 2015
0
55
Tumors require blood to emerge and spread. That is why scientists at The University of Texas MD Anderson Cancer Center believe that targeting blood vessel cells known as pericytes may offer a potential new therapeutic approach ...
Feb 19, 2015
0
32
(HealthDay)—A drug to treat the most common eye disease among diabetics has been approved by the U.S. Food and Drug Administration.
Feb 9, 2015
0
5
Stanford University School of Medicine scientists have found a new way to forecast which patients with age-related macular degeneration are likely to suffer from the most debilitating form of the disease.
Nov 5, 2014
0
0
A major medical discovery by scientists at The University of Nottingham could lead to the development of an entirely new type of painkiller.
Oct 1, 2014
0
0
Possibility of developing new, more selective drugs to control the abnormal growth of blood vessels and prevent blindness including retinopathy of prematurity, a disorder that may result in retinal detachment due to abnormal ...
Sep 16, 2014
0
0
Neovascular age-related macular degeneration (AMD), which involves formation of abnormal blood vessels in the retina, is a leading cause of vision loss. A subgroup of neovascular AMD, known as retinal angiomatous proliferation ...
Sep 4, 2014
0
0
